TNNT2
Troponin T, cardiac muscle
Also known as: CMD1D, CMH2, CMPD2, TNNT2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P45379
- Gene
- TNNT2
- Ensembl
- ENSG00000118194
- Chromosome
- 1
- Canonical length
- 298 aa
- Protein class
- Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules
OverviewNCBI Gene
This gene encodes the cardiac isoform of troponin T. The encoded protein is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in this gene have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
298 residues, UniProt reviewed canonical sequence.
>P45379|TNNT2
1 MSDIEEVVEE YEEEEQEEAA VEEEEDWRED EDEQEEAAEE DAEAEAETEE TRAEEDEEEE
61 EAKEAEDGPM EESKPKPRSF MPNLVPPKIP DGERVDFDDI HRKRMEKDLN ELQALIEAHF
121 ENRKKEEEEL VSLKDRIERR RAERAEQQRI RNEREKERQN RLAEERARRE EEENRRKAED
181 EARKKKALSN MMHFGGYIQK QAQTERKSGK RQTEREKKKK ILAERRKVLA IDHLNEDQLR
241 EKAKELWQSI YNLEAEKFDL QEKFKQQKYE INVLRNRIND NQKVSKTRGK AKVTGRWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNNT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 8,732 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 8,732 nTPM
- blood vessel: 57 nTPM
- kidney: 46 nTPM
- cerebral cortex: 29 nTPM
- urinary bladder: 24 nTPM
- skin: 20 nTPM
Single-cell type
- cardiomyocytes: 199 nCPM
- podocytes: 113 nCPM
- brain excitatory neurons: 11 nCPM
- epicardial cells: 6.8 nCPM
- proximal tubule cells: 3.4 nCPM
- adipocytes: 1.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 18 nTPM
- hippocampal formation: 11 nTPM
- white matter: 8.8 nTPM
- basal ganglia: 1.8 nTPM
- cerebellum: 0.4 nTPM
- choroid plexus: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNNT2.
Disease | AllUniProt
Conditions TNNT2 is implicated in, by any mechanism.
- Cardiomyopathy, familial hypertrophic, 2 (CMH2) MIM:115195
- Cardiomyopathy, dilated, 1D (CMD1D) MIM:601494
- Cardiomyopathy, familial restrictive 3 (RCM3) MIM:612422
Disease | GeneticClinVar
66 pathogenic / likely-pathogenic of 1,146 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypertrophic cardiomyopathy 2
- Dilated cardiomyopathy 1D
- Cardiomyopathy, familial restrictive, 3
- Hypertrophic cardiomyopathy
- Cardiovascular phenotype
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle contraction
- muscle filament sliding
- negative regulation of ATP-dependent activity
- positive regulation of ATP-dependent activity
- regulation of heart contraction
- regulation of muscle contraction
- response to calcium ion
- sarcomere organization
- ventricular cardiac muscle tissue morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNNT2 as an antibody target. Whether an autoantibody or antibody against TNNT2 could matter depends on whether native TNNT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNNT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNNT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...